2cureX AB Marks Milestone with First Direct-to-Patient Cancer Test in Europe
2cureX AB, a Swedish biotech company, has achieved a significant milestone in cancer treatment by conducting its first direct-to-patient IndiTreat test, marking a shift towards personalized medicine in oncology care.
2 minutes to read